A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

NCT05741294 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Tirbanibulin 2.5 mg ointment

Sponsor

Almirall, S.A.